Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metformin and mortality.

Literature DB >> 23377620

Metformin and mortality.

S S Lund.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2013 PMID： 23377620 DOI： 10.1007/s00125-013-2843-y

Source DB: PubMed Journal: Diabetologia ISSN： 0012-186X Impact factor: 10.122

× No keyword cloud information.

8 in total

1. Metformin and risk of cardiovascular disease.

Authors: R C Turner; R R Holman
Journal: Cardiology Date: 1999 Impact factor: 1.869

2. The UK Prospective Diabetes Study.

Authors: M Evans
Journal: Lancet Date: 1998-12-12 Impact factor: 79.321

Review 3. Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

Authors: R J Stevens; R Ali; C R Bankhead; M A Bethel; B J Cairns; R P Camisasca; F L Crowe; A J Farmer; S Harrison; J A Hirst; P Home; S E Kahn; J H McLellan; R Perera; A Plüddemann; A Ramachandran; N W Roberts; P W Rose; A Schweizer; G Viberti; R R Holman
Journal: Diabetologia Date: 2012-08-10 Impact factor: 10.122

Review 4. Mitochondria and cardiovascular aging.

Authors: Dao-Fu Dai; Peter S Rabinovitch; Zoltan Ungvari
Journal: Circ Res Date: 2012-04-13 Impact factor: 17.367

5. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors:
Journal: Lancet Date: 1998-09-12 Impact factor: 79.321

6. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.

Authors: Adriaan Kooy; Jolien de Jager; Philippe Lehert; Daniël Bets; Michiel G Wulffelé; Ab J M Donker; Coen D A Stehouwer
Journal: Arch Intern Med Date: 2009-03-23

7. Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.

Authors: Bruna Corominas-Faja; Rosa Quirantes-Piné; Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Sílvia Cufí; Begoña Martin-Castillo; Vicente Micol; Jorge Joven; Antonio Segura-Carretero; Javier A Menendez
Journal: Aging (Albany NY) Date: 2012-07 Impact factor: 5.682

Review 8. AMP-activated protein kinase: a target for drugs both ancient and modern.

Authors: D Grahame Hardie; Fiona A Ross; Simon A Hawley
Journal: Chem Biol Date: 2012-10-26